08:00-08:50 |
Morning Session 1 (Novartis) |
Morning Session 2 (Servier) |
Morning Session 3 (Pfizer) |
Morning Session 4 (Hanmi Pharm) |
08:50-09:00 |
Break |
09:00-10:30 |
Big Conversations with World's Leaders about Conundrums of Heart Failure |
Epidemiology of Heart Failure in Big Data Era |
Telemonitoring and New Device in Heart Failure |
How to Manage Cardiogenic Shock |
10:30-11:00 |
Coffee Break |
11:00-12:30 |
[Joint Session with HFSA] Implementation of the Four-Pillars in HFrEF
|
Blood Pressure in Heart Failure: What's New? |
Recent Landmark Clinical Trials and New Post-hoc Analysis |
Pregnancy and Heart Failure: Always in Peril |
12:30-13:30 |
Luncheon Session 5 (Novartis) |
Luncheon Session 6 (Daewoong) |
Luncheon Session 7 (Boehringer Ingelheim+Eil Lilly) |
Luncheon Session 8 (Novartis) |
13:30-15:00 |
[Joint Session with CHFA] Various Debating Issues in the Field of HFpEF
|
A Deep Dive into SGLT2 Inhibitors |
Young Investigator Award |
Caring Patients with Heart Failure at the End of Life |
15:00-15:20 |
Coffee Break |
15:20-16:50 |
[Joint Session with ESC-HFA] New Insight for HFmrEF and HFpEF
|
The Reciprocal Relationship Between Mental and Heart Health |
Experience and New Perspectives on Heart Transplant Management |
Best Oral Presentation Award |
16:50-17:00 |
Break |
17:00-17:50 |
Interactive Case Debate Session-4Patient Selection for SGLT-2 Inhibitor: Interactive
|
Interactive Case Debate Session-5 Bad Complications in LVAD
|
Interactive Case Debate Session-6How to Do in Atrial Cardiomyopathy
|
Cardiorenal Syndrome in Heart Failure |
18:10-21:00 |
Reception + Presidential Dinner (2F) |